logo-loader
AIM:AGL

ANGLE PLC

Receive alerts
Market:
AIM
Market Cap:
£92.27 m
Price
53.40 GBX
Change
1.71%
52 weeks high
85.00
52 weeks low
40.00

In brief

ANGLE PLC develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease.

Deep dive We explore the investor case for growth companies

Snapshot

  • ANGLE is developing Parsortix blood test that can detect cancer
  • Healthy cash balance
  • Other tests in development